The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 26, 2025
Filed:
Apr. 15, 2021
Applicant:
The Scripps Research Institute, La Jolla, CA (US);
Inventors:
Raiees Andrabi, La Jolla, CA (US);
Dennis Burton, La Jolla, CA (US);
Assignee:
THE SCRIPPS RESEARCH INSTITUTE, La Jolla, CA (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 5/08 (2006.01); A61K 9/127 (2006.01); A61K 9/51 (2006.01); A61K 39/00 (2006.01); A61K 39/21 (2006.01); A61K 39/39 (2006.01); A61K 47/08 (2006.01); A61K 47/10 (2017.01); A61P 31/18 (2006.01); C12N 7/00 (2006.01); C12N 15/86 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
C07K 5/08 (2013.01); A61K 9/127 (2013.01); A61K 9/51 (2013.01); A61K 39/21 (2013.01); A61K 39/39 (2013.01); A61K 47/08 (2013.01); A61K 47/10 (2013.01); A61P 31/18 (2018.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); G01N 33/56988 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55566 (2013.01); C12N 2740/15022 (2013.01); C12N 2740/15034 (2013.01); C12N 2750/14143 (2013.01);
Abstract
The present application relates to epitope-targeted SIV and HIV vaccines. The invention provides novel envelope glycoproteins which may be utilized as HIV-1 vaccine immunogens, antigens for crystallization, and for identification of broadly neutralizing antibodies. The invention encompasses preparation and purification of immunogenic compositions which are formulated into vaccines of the present invention.